Cardiometabolic and Skeletal Risk Factors in Black Men with Prostate Cancer Starting Androgen Deprivation Therapy

por Gunnarsson, Orvar, Basaria, Shehzad, Gignac, Gretchen A.
Publicado 2015

Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care

por Gunn, Christine M., Li, Emma X., Gignac, Gretchen A., Pankowska, Magdalena, Loo, Stephanie, Zayhowski, Kimberly, Wang, Catharine
Publicado 2023

Risk factors involved in treatment delays and differences in treatment type for patients with prostate cancer by risk category in an academic safety net hospital

por Kan, Carolyn K., Qureshi, Muhammad M., Gupta, Apar, Agarwal, Ankit, Gignac, Gretchen A., Bloch, B. Nicolas, Thoreson, Nicholas, Hirsch, Ariel E.
Publicado 2017

Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic disease

por Jafari, Naser, Chen, Andrew, Kolla, Manohar, Pompa, Isabella R., Qiu, Yuhan, Yu, Rebecca, Llevenes, Pablo, Ennis, Christina S., Mori, Joakin, Mahdaviani, Kiana, Halpin, Meredith, Gignac, Gretchen A., Heaphy, Christopher M., Monti, Stefano, Denis, Gerald V.
Publicado 2022